A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...

Fully human intranasal foralumab shows promise in treating Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS.

Virtual Fireside Chat 1x1 Meetings: Please contact your Roth representative. A webcast of the presentation will be available on the “ Events ” section of the Clene website. Alternatively, one can ...

Sir Chris Hoy and his wife Sarra have been diagnosed with stage four prostate cancer and multiple sclerosis respectively, ...

Find insight on Merck KGaA, Bayer, Jazz Pharmaceuticals and the use of AI in China’s healthcare sector in the latest Market ...

A Co Down woman, who was disagnosed with multiple sclerosis (MS) when she was 24, is sharing her experience as new research ...

Tolebrutinib is more effective in reducing the risk of disability progression in MS patients with paramagnetic rim lesions, ...

Brittany Boudreau got a tattoo that reads “Somewhere weakness is our strength." It's now her motto for living with MS.

Autoimmune diseases disproportionately affect women, and Black women face higher rates of misdiagnosis, delayed treatment, ...

Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who had a greater number of MRI paramagnetic rim lesions at baseline, data show ...